Here's why I think the Sonic Healthcare share price could jump higher

Increasing COVID-19 testing in this third wave of Omicron could lead to resurgent earnings.

| More on:
Medical technicians wearing white medical coats conduct a test in a laboratory.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Sonic Healthcare is a key player in the COVID testing space
  • Another wave has started in Australia, which could lead to more testing
  • Sonic Healthcare can use its elevated profit to make acquisitions and return cash to shareholders

The Sonic Healthcare Limited (ASX: SHL) share price could be a leading opportunity right now, in my opinion.

Sonic Healthcare is one of the leading global pathology businesses, with operations in Australia, New Zealand, North America, and Europe.

Since the start of 2022, the Sonic Healthcare share price has dropped back by 27%. I think the business looks good value with what's going on in the healthcare space.

Third wave of Omicron to lead to more testing?

Over the past two and a half years, COVID testing has helped the company's revenue and net profit after tax (NPAT) significantly.

According to Sonic's FY22 half-year result, its revenue increased 7% year over year to $4.76 billion. Net profit went up 22% to $828 million. But, the base revenue (which excludes COVID revenue) increased 4.3% year over year.

Over the FY22 first half, the Sonic Healthcare share price increased by 22.5%.

Sonic management is expecting ongoing growth of the base business, with "strong underlying drivers, including catch-up of testing postponed through pandemic".

COVID-19 cases are now increasing, as are hospitalisations, as a third wave of Omicron sweeps across Australia.

The federal chief health officer, Paul Kelly, has warned this is the "start of this wave, not the end", according to reporting by The Guardian.

Calls to get a PCR test despite a negative RAT

Concession card holders will now have continued access to free RAT tests through their local pharmacies. The program has been extended until 31 July.

Australian Medical Association vice president Dr Chris Moy said people who return a negative RAT test but continue to experience symptoms should have a PCR test.

Moy told ABC Radio Sydney:

A positive is a positive. The issue is you can't rely on a negative if you continue to have symptoms… By the time [a RAT] may go positive, it may be too late to get these antivirals.

We need you to go out there straight away, get a PCR test. If you're positive then we can get the ball rolling to give you these potentially life-saving treatments.

I think these different factors could lead to a resurgence of PCR testing, which would be a boost for Sonic's earnings and therefore, potentially, the Sonic Healthcare share price.

Even after this wave, I think Sonic's previous comments about expectations of ongoing COVID testing are almost as relevant now as they were with the FY22 half-year result:

[We] expect a sustainable level of COVID testing into the future, including routine COVID testing, screening programs, variant testing, whole genome sequencing, antibody tests.

Profit can be used to boost shareholder returns

I like that Sonic Healthcare has been using some of its elevated cash flow to make acquisitions to boost long-term growth.

For example, over the past 12 months it has bought ProPath in Dallas. ProPath makes US$110 million in revenue. It's also bought Canberra Imaging Group in Australia, which makes $60 million in revenue.

It could continue to make earnings-boosting acquisitions, too.

Sonic Healthcare has a progressive dividend policy. It has also launched a $500 million on-market share buyback.

Foolish takeaway

I think that the Sonic Healthcare share price is attractive because of the ongoing growth of its base business, the ageing demographic tailwinds, continuing COVID-19 testing, a growing dividend, and the ability for the business to keep putting excess cash to good use with acquisitions and share buybacks.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

An ASX 200 market analyst holds his hand to his chin and looks closely at his computer screens watching share price movements
Opinions

Forget term deposits! I'd buy these two ASX 200 stocks instead

I think ASX stocks could make a much better investment than term deposits.

Read more »

share buyers, investors, happy investors
ETFs

How I would build a $100,000 portfolio with ASX ETFs today

You don't need more than three ETFs to build a diversified portfolio...

Read more »

iPhone with the logo and the word Google spelt multiple times in the background.
Opinions

I've been buying these 2 US stocks in 2025. Here's why

Sometimes the US markets are a better place to go shopping for stocks.

Read more »

A man and woman sit next to each other looking at each other and feeling excited and surprised after reading good news about their shares on a laptop.
Opinions

Where I'd invest in ASX shares after the RBA interest rate cut

These stocks look really attractive to me. Here’s why…

Read more »

Miner looking at a tablet.
Opinions

3 reasons why the Fortescue share price could still be a buy

Let’s dig into why this mining giant could be a solid buy.

Read more »

A young woman wearing a red and white striped t-shirt puts her hand to her chin and looks sideways as she wonders whether to buy NAB shares
Opinions

The pros and cons of buying Wesfarmers shares in May

Is this retail giant an appealing opportunity?

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Opinions

2 ASX 200 shares that I think are still bargains after the market rally

These businesses look like attractive opportunities. Here’s why…

Read more »

A young woman looks at something on her laptop, wondering what will come next.
Opinions

Worried about another stock market sell-off?

Market declines don’t need to be too scary.

Read more »